Cargando…
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Massachusetts Medical Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117967/ https://www.ncbi.nlm.nih.gov/pubmed/33951357 http://dx.doi.org/10.1056/NEJMc2104974 |
| _version_ | 1783691668143210496 |
|---|---|
| author | Abu-Raddad, Laith J. Chemaitelly, Hiam Butt, Adeel A. |
| author_facet | Abu-Raddad, Laith J. Chemaitelly, Hiam Butt, Adeel A. |
| author_sort | Abu-Raddad, Laith J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8117967 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Massachusetts Medical Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81179672021-05-18 Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants Abu-Raddad, Laith J. Chemaitelly, Hiam Butt, Adeel A. N Engl J Med Correspondence Massachusetts Medical Society 2021-05-05 /pmc/articles/PMC8117967/ /pubmed/33951357 http://dx.doi.org/10.1056/NEJMc2104974 Text en Copyright © 2021 Massachusetts Medical Society. All rights reserved. http://www.nejmgroup.org/legal/terms-of-use.htm This article is made available via the PMC Open Access Subset for unrestricted re-use, except commercial resale, and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the Covid-19 pandemic or until revoked in writing. Upon expiration of these permissions, PMC is granted a license to make this article available via PMC and Europe PMC, subject to existing copyright protections. |
| spellingShingle | Correspondence Abu-Raddad, Laith J. Chemaitelly, Hiam Butt, Adeel A. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants |
| title | Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants |
| title_full | Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants |
| title_fullStr | Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants |
| title_full_unstemmed | Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants |
| title_short | Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants |
| title_sort | effectiveness of the bnt162b2 covid-19 vaccine against the b.1.1.7 and b.1.351 variants |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117967/ https://www.ncbi.nlm.nih.gov/pubmed/33951357 http://dx.doi.org/10.1056/NEJMc2104974 |
| work_keys_str_mv | AT aburaddadlaithj effectivenessofthebnt162b2covid19vaccineagainsttheb117andb1351variants AT chemaitellyhiam effectivenessofthebnt162b2covid19vaccineagainsttheb117andb1351variants AT buttadeela effectivenessofthebnt162b2covid19vaccineagainsttheb117andb1351variants |